FDA urges patients to keep taking contaminated blood pressure drugs

Many valsartan-containing drugs have been recalled for a carcinogen. Amid shortages of untainted drugs, the FDA says not taking them poses a greater risk than the low levels of carcinogen does.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news